Drug information for ORTHO-NOVUM 7/7/7-21

Form	Dosage	Status	Therapeutic Equivalence	Active Ingred	Ref.	Sponsor	Document
TABLET; ORAL-21	0.035MG,0.035MG,0.035MG;0.5MG,0.75MG,1MG	Discontinued		ETHINYL ESTRADIOL; NORETHINDRONE	Norethindrone	JANSSEN PHARMS	18985

Drug Adverse Effects information for ORTHO-NOVUM 7/7/7-21

Role code	Indications	Reaction	# Reports
C	ACNE	CHOLECYSTITIS CHRONIC	2
C	ACNE	EMOTIONAL DISTRESS	2
C	ACNE	GALLBLADDER DISORDER	2
C	ACNE	PAIN	2
C	ANXIETY	ILEITIS	1
C	ANXIETY	INJECTION SITE ERYTHEMA	1
C	ANXIETY	PNEUMONIA	1
C	ANXIETY	URINARY TRACT INFECTION	1
C	CONTRACEPTION	ILEITIS	1
C	CONTRACEPTION	INJECTION SITE ERYTHEMA	1
C	CONTRACEPTION	PNEUMONIA	1
C	CONTRACEPTION	URINARY TRACT INFECTION	1
C	GLUCOSE TOLERANCE IMPAIRED	ILEITIS	1
C	GLUCOSE TOLERANCE IMPAIRED	INJECTION SITE ERYTHEMA	1
C	GLUCOSE TOLERANCE IMPAIRED	PNEUMONIA	1
C	GLUCOSE TOLERANCE IMPAIRED	URINARY TRACT INFECTION	1
C	MULTIPLE SCLEROSIS	ILEITIS	1
C	MULTIPLE SCLEROSIS	INJECTION SITE ERYTHEMA	1
C	MULTIPLE SCLEROSIS	PNEUMONIA	1
C	MULTIPLE SCLEROSIS	URINARY TRACT INFECTION	1
C	PREMEDICATION	ILEITIS	1
C	PREMEDICATION	INJECTION SITE ERYTHEMA	1
C	PREMEDICATION	PNEUMONIA	1
C	PREMEDICATION	URINARY TRACT INFECTION	1
C	PREMENSTRUAL SYNDROME	CHOLECYSTITIS CHRONIC	2
C	PREMENSTRUAL SYNDROME	EMOTIONAL DISTRESS	2
C	PREMENSTRUAL SYNDROME	GALLBLADDER DISORDER	2
C	PREMENSTRUAL SYNDROME	PAIN	2

Ads by Google